Kim Baden-Kristensen is the CEO and Co-founder of Brain+, specializing in digital therapeutics for brain rehabilitation and remediation.
The award winning Brain+ apps are validated in clinical pilot trials and are undergoing large scale pivotal clinical trials in Brain injury (TBI and stroke), Parkinson’s disease and Major depressive disorder patients. Brain+ also works on presymptomatic detection and prevention of Alzheimer’s disease in collaboration with leading European universities, providers, and patient organizations, including Alzheimer Europe and the European Brain Council.
Kim is a founding member of the Digital Therapeutics Partnership, a global non-for-profit with a mission to enhance patient outcomes and quality of care with clinically-validated digital therapeutics. He is intensively engaged in health care policy making initiatives on the European level.
Kim is recognized as an authority within digital cognitive therapeutics, with particularly emphasis on neurogame-based rehabilitation and “gamified” rehabilitation.
Kim holds an MSc. In Innovation Management from Copenhagen Business School, a Health Care Innovation degree from Harvard Business School, and a minor in Cognitive Neuroscience from Copenhagen University.
Improving Neurorehabilitation through Gaming and Digital Therapy
Combining the knowledge of neuroscience with gameplay, neurogaming is set to be a major disruptor in the future of healthcare. Incorporating sensory, cognitive, emotional and behavioral technologies, game creators are expected to be able to develop games that will improve both health and brainpower.
Games focused on attention, complex cognitive challenges and mindfulness are just the start as researchers look for solutions for patients suffering from cognitive impairments related to e.g. Traumatic Brain Injury, Stroke, Depression, Parkinson’s disease, Alzheimer’s disease.
Real computer games + validated neuroscience = Improved patient outcomes and quality of care
EVEN MORE SEMINARS
Priya Rogers Brainbook
Brainbook: Neurosurgery for all
Tina Soulis Neuroscience Trials Australia
Strategies in CNS Drug and Device Development: The Australian Advantage
Bankole Akomolafe Hull and East Yorkshire Hospitals NHS Trust
The USS in Carotid surgery
Dr Jenny Freeman Plymouth University
Rehabilitation strategies for progressive multiple sclerosis: an overview of evidence
Neelam Kaur Premium Care Solutions
Complex Care at Home: The good, the bad and the extraordinary